M Koizumi1, Y Yamada, T Takiguchi
1Department of Nuclear Medicine, Cancer Institute Hospital, Tokyo, Japan.
Bone metabolic markers, osteoclastic and osteoblastic, significantly increase with bone metastasis. Osteoclastic markers, particularly serum pyridinoline-cross-linked carboxyterminal telopeptide, show high efficiency in detecting bone metastasis across various cancers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: